Discontinued — last reported Q4 '18
An increase suggests successful diversification or growth in secondary revenue streams, while a decrease may indicate declining demand for niche products or reduced service-related income.
This metric represents the revenue generated from secondary product lines, service agreements, or ancillary commercial a...
Peers in the biopharmaceutical industry often report similar 'other' revenue categories, which typically include royalties, milestone payments, or minor product lines that supplement core therapeutic sales.
incy_segment_product_and_service_other_revenues